The Patent Finder
US

2,4-Disubsituted Thiazoles and Pharmaceutical Compositions Thereof

US 8,227,495 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Jul 24, 2024 on the fee record · Medium confidence

Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.

Third maintenance fee unpaid; grace period ended.

Filed Aug 14, 2009 as application 12/541,865 · Granted Jul 24, 2012
Base term, 20 years from filing, plus 105 days of patent term adjustment (USPTO delay)
Today
Lapsed Jul 24, 2024
2007 2028
Clock starts
Dec 26, 2007
No longer in force
Jul 24, 2024
Granted
Jul 24, 2012
Term would have run to
Apr 9, 2028
base term patent term adjustment after the term ends fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
105
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Apr 9, 2028: its 20-year base term plus 105 days of term adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 26, 2007, when application 11/964,461, the earliest non-provisional in its chain, was filed (this one was filed Aug 14, 2009)Dec 26, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+105 days, USPTO patent term adjustment recordApr 9, 2028High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidlapsed Jul 24, 2024High confidence
Computed term endThe steps above, in orderJul 24, 2024Medium confidence

This family

US 7,638,541In force
Dec 2027
Dec 2027
Application PCT/US2007/088978PCT application
no patent term
no patent term
US 8,227,495this patent
Jul 2024
Jul 2024
US 8,288,384Lapsed on the fee record
Oct 2024
Oct 2024
US 8,975,258In force
May 2028
May 2028
US 8,921,350In force
no later than Dec 2027
no later than Dec 2027
Application 14/626,749Abandoned
not computed
not computed
US 9,737,537Lapsed on the fee record
Aug 2025
Aug 2025
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 14, 2009
Reel 23103, frame 696
Chen, Xin; Cheng, Peng; Clemens, L. Edward; Johnson, Jeffrey D; Ma, Jingyuan; Murphy, Alison; Nashashibi, Imad; Rabbat, Christoper J; Song, Jiangao; Wilson, Maria E; Zhu, Yan; Zhao, ZuchunMetabolex Inc.Assignment of Assignor's Interest
Nov 6, 2013
Reel 31589, frame 193
Metabolex, Inc.Cymabay Therapeutics, Inc.Change of Name
Nov 22, 2013
reel/frame not recorded
Cymabay Therapeutics, Inc.Silicon Valley BankSecurity Agreement
Nov 22, 2013
reel/frame not recorded
Cymabay Therapeutics, Inc.Oxford Finance LLCSecurity Agreement
Nov 22, 2013
Reel 31710, frame 508
Cymabay Therapeutics, Inc.Silicon Valley Bank; Oxford Finance LLCSecurity Agreement
Aug 7, 2015
Reel 36307, frame 406
Silicon Valley Bank; Oxford Finance LLCCymabay Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited